PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 1

Transforming the Biologics Product Lifecycle with Inhalation Innovation

In recent years, the biopharmaceuticals landscape has witnessed a revolutionary shift with the emergence of new nasal inhalation technologies. Among these, soft mist...
Continue Reading →
Volume 15 Issue 2

How to Harness the Benefits of Inhalation When Re-formulating Biologics

The biologics market is growing rapidly and is on track to be worth $719.14 bn by 2030, up from $366.6 bn in 2021.¹ This growth is being driven primarily by the risi...
Continue Reading →
Volume 15 Issue 1

Local Lung Delivery for Small and Large Molecules Via Dry Powder Inhaler

Inhalation is a familiar route of delivery for many drugs designed to treat asthma and related conditions. Asthmatics routinely carry some form of metered dose inhal...
Continue Reading →
News

Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at CPhI China 2018

Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at the Shanghai ...
Continue Reading →
News

Lactohale 206, a new tool for QbD for Dry Powder Inhalation

The DFE Pharma product portfolio for Dry Powder Inhalation contains a full range of lactose grades with different properties, which can be further optimised in colla...
Continue Reading →
News

Next Breath Announces Injectable, Extractable and Leachable Services

Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP analytical services to include development services for injectable de...
Continue Reading →
News

Phillips-Medisize Exhibits During DDL2017

Phillips-Medisize will exhibit at the Drug Delivery to the Lungs Conference, which is taking place at Edinburgh International Conference Center on December 6-8, 2017...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026